I is a pleasure to have the opportunity of contributing and sharing experiences with the readers of the British Journal of Rheumatology. When I finished my internal medicine and rheumatology training in a first rate university hospital at Mexico City with Dr Donato Alarcon-Segovia, I came back to Colombia and decided to settle down in my hometown, Barranquilla. Colombia has a population of about 35 million people and just about 75 certified rheumatologists (one rheumatologist for half a million people). As in other places in South America, more than 80% of the rheumatologists are located in the five main cities (Bogota´, Medellı´n, Cali, Barranquilla and Cartagena) . In Barranquilla there are seven rheumatologists for 1.5 million people (one rheumatologist for each 215 000 people) but a catchment area of 7 million people including people from the Caribbean area (San Andres, Aruba, etc.). Anyway, in the attending rheumatology practice, although we are few rheumatologists, we face 'official competition' from orthopaedics, fisiatrists, general internists and general practitioners and 'unofficial' competition from homeopathic medicine, witched individuals such as 'The Amazonic Indian', and even some kind of popular 'saints' such as JoseǴ regorio Herna´ndez, a former medical doctor who died early this century and is now very popular performing all kind of 'miracles'.
Most people do not have an exact idea of who or what a rheumatologist is and does and it is not infrequent to have a consultation because of a 'rheuma', meaning the nasal fluid of a rhinitis.
In the Colombian Rheumatology Association, we have an ambitious and very important programme of spreading knowledge about arthritis, rheumatology and rheumatologists. We arrange frequent talks and meetings in intermediate and small cities, creating local friendship and generating referral patterns of people with rheumatic diseases. Every 2 yr, we have our national meeting, the last (fifth national congress) was held in Barranquilla and the next (sixth national congress) is in May 1997 in Bucaramanga. As a result of our programmes, in Barranquilla we had the national record of 1500 attendants, including students, general practitioners, internists, orthopaedics and other related health professionals interested in the rheumatic diseases. We had 12 international speakers, including Theodore Pincus, Kenneth Calamia and Antonio Reginato from the USA, Jorge Alcocer-Varela and Mario Cardiel from Mexico, Aurelio Rapado from Spain, Charles Menkes and Katherine la Cornier from France and Munther Kamashta from England. More than 80 original papers were presented at the meeting. The congress had two attached courses, one on crystal deposition diseases by Dr Reginato and the other one on investigation and epidemiology of rheumatic diseases (obligatory for trainees) with Dr Cardiel who is developing a better attitude to clinical research and investigation in our younger members.
Nowadays, research areas include rheumatoid arthritis, systemic lupus erythematosus, osteoporosis, Sjo¨gren's syndrome and vasculitis.
Rheumatologists have taken the leadership in the investigation and study of osteoporosis, and recently we had the First National Consensus Meeting on reporting of bone densitometry and diagnosis of osteoporosis, since most of the bone densitometers are operated by rheumatologists.
Our disease panorama is wide and, in private practice, we see numerous patients with extra-articular rheumatism, fibromyalgia and myofascial syndromes as well as inflammatory diseases, mainly rheumatoid arthritis and seronegative spondyloarthropathies. Osteoarthritis and osteoporosis also are prevalent. In institutional practice, inflammatory diseases are prevalent, rheumatoid arthritis being the most common one. We have to face two 'disseminated' additional 'diseases'. The first one is the 'ASTO disease', consisting of patients and general practitioners attributing to all kinds of rheumatic complaints, in all ages, to an elevation of the antistreptolysin titre. You may have a hard time trying to explain to a patient as well as to a GP that there are other kinds of arthritis besides rheumatic fever. The indiscriminate use of penicillin and other antibiotics has tended to eliminate rheumatic fever as an important disease in our country. The other disseminated disease is 'uric acid disease', with similar characteristics as 'ASTO disease', but in this case all complaints are blamed on uric acid levels. It seems obligatory to suspend all types of red meat. So when you try to explain the seven very rational 1987 American College of Rheumatology Criteria for diagnosis of a high-titre seropositive rheumatoid arthritis for about an hour, you can face a question like: 'Are you going to treat my ASTO titre, Doc.? How many times do I have to get a Bencetazil September 1996. (Benzatinic penicillin) shot? What about my 7.2 mg/dl uric acid levels? I took urocuad and suspended meat 15 days and got much better!!'
A few months ago, as a kind of 'outreach clinics' programme of the university, I went to 'La Guajira', a region located in the northern part of Colombia and South America. It is about 6 h (2 1 2 h of which on rural ways) away from Barranquilla and I spent 2 days trying to find rheumatic diseases, especially spondyloarthropathies in an Indian community called the 'Wayuu Community'. I needed a translator from Wayunni (the native language) to Spanish and I was surprised because everybody seemed to have rheumatic complaints (spondylitis, fibromyalgia, hepatitis B and delta associated rheumatic complaints??, I thought). I was soon disappointed because I discovered the reason for these rheumatic complaints 'epidemics'; they faked rheumatic symptoms to get all kinds of free medicines because they used to exchange blood donoring for medicines (this is a high hepatitis B and delta area, and is a very important research area for the department of immunogenetics of my university). Anyway, I learned some Wayunni, slept in a chinchorro (a big kind of hammock) and saw the most spectacular sunset I can remember.
In 1993, the government carried out the second most important health reform in 60 yr in the social security system. Until 1993, coverage of the social security system was only near to 30% of the population. In the new reform, the government expects 100% coverage at the beginning of the next century. The reform establishes a government-regulated system with several kinds of public and private health maintenance organizations (HMO) who get the people and the funds into the system, and a lot of health care organizations founded by all kinds of health institutions and physicians giving health care. If you do not want to go to the health system, you can have private attention (every day there are fewer private patients) or special prepaid medicine from the HMO (every day HMO patients are growing up). The administration of prepaid medicine and the new health reform by private HMO used to care little about the doctors or patients, but only about the costs; the weakest side being salary and conditions for physicians (a medical appointment with a rheumatologist costs between 5 and 7 dollars in the health system, 17-20 US dollars in prepaid medicine and 35-40 US dollars in private practice) and generating a powerful medical resistance to the new health reform.
In Barranquilla, the fourth city of the country, 32 medical associations and their presidents founded a year ago a College of Medical Associations with a little more than 1000 postgraduate doctors and made a big strike against the private HMOs and prepaid medicine. The aim of the strike was based in three facts: (1) opening of medical directories to all medical doctors certified by a Medical Association since HMOs used to have secret medical directories to control prices and physicians; (2) on-time payment of honoraria since most of the HMOs used to pay between 2 and 6 months later to the physicians; and (3) bilateral concertation of medical honoraria, since HMOs used to set the honorarium fees unilaterally.
One year later, after a long and very difficult fight, all but two of the 15 HMOs have made arrangements with the College of Medical Associations. Now we have as rheumatologists an open directory and a scale of points of relative value unit (RVU) (e.g. appointment: 6 RVU; local tissue injection: 9 RVU; arthrocentesis: 12 RVU; salivary gland biopsy: 20 RVU, etc.) and we set the value of the RVU with the HMOs (e.g. with an RVU of 5 US dollars, an appointment is 30 US dollars and an arthrocentesis is 60 US dollars) so we forgot about discussing all prices, but just the RVU cost. We are working on a diagnosis-related score for the RVU and studying real costs of all interventions as rheumatologists. Yet, HMOs do not pay honoraria on time, but now we have a committee with representatives of Medical Associations and the HMOs working on it and other common issues. People feel better because now they can go to the doctor of their choice. The road is long and the unity of medical doctors has been the main factor in the success and defence of the rights of our practice. Now, other places in Colombia are trying to pursue the same course.
Despite all the problems and changes within the health system and its economic constraints, the poverty of 30-40% of our population, the drugs and drug-cartel problems, I am sure you can find in Colombia a young, working and growing country which is beautiful, difficult to understand, but really determined to make its way into the new millennium with a strong first world rheumatology practice and with the local flavour of an each day less underdeveloped world.
